07:00 , Oct 3, 2011 |  BC Week In Review  |  Financial News

MSI completes venture financing

MSI Methylation Sciences Inc. , Vancouver, B.C.   Business: Neurology   Date completed: 9/29/11   Type: Venture financing   Raised: €13.5 million ($18.1 million)   Investors: Inventages Venture Capital; Working Opportunity Fund; GrowthWorks Capital; BC...
00:04 , Sep 30, 2011 |  BC Extra  |  Financial News

MSI raises EUR 13.5 million

MSI Methylation Sciences Inc. (Vancouver, B.C.) raised EUR 13.5 million ($18.1 million) in a series A round led by Inventages Venture Capital. The Working Opportunity Fund; GrowthWorks; BC Advantage Funds; and angel investors also participated....
07:00 , Jun 21, 2010 |  BC Week In Review  |  Financial News

Aquinox completes venture financing

Aquinox Pharmaceuticals Inc. , Vancouver, B.C.   Business: Cancer, Inflammation   Date completed: 6/17/10   Type: Venture financing   Raised: $25 million   Investors: Ventures West; Pfizer Venture Investments; Johnson & Johnson Development Corp.; Baker...
00:22 , Jun 18, 2010 |  BC Extra  |  Financial News

Aquinox raises $25 million

Aquinox Pharmaceuticals Inc. (Vancouver, B.C.) raised $25 million in a series B round led by existing investor Ventures West. New investor Pfizer Venture Investments joined other existing investors Johnson & Johnson Development Corp.; Baker Brothers;...
07:00 , Sep 21, 2009 |  BC Week In Review  |  Financial News

Urodynamix completes private placement

Urodynamix Technologies Ltd. (TSX-V:URO), Vancouver, B.C.   Business: Diagnostic   Date completed: 9/11/09   Type: Private placement   Raised: C$1.5 million (US$1.4 million)   Shares: 30 million   Price: C$0.05   Shares after offering: 137.4...
01:31 , Jun 3, 2008 |  BC Extra  |  Financial News

Inimex raises $22 million

Inimex (Vancouver, B.C.) raised $22 million in a series B round led by new investor Morningside Venture Investments. Roche Venture Fund; Astellas Venture Management; and Advantage Life Science Fund II, also new investors, joined existing...
07:00 , Jul 16, 2007 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Aquinox Pharmaceuticals Inc. Vancouver, B.C. Technology: Small molecules that agonize or antagonize SH2-containing inositol phosphatase ( SHIP ) and SHIP-2 Disease focus: Cancer, inflammation, autoimmune Clinical status: Preclinical Founded: 2004 by Raymond Anderson, Gerald Krystal,...
01:10 , Jun 13, 2007 |  BC Extra  |  Financial News

Aquinox raises $14.5 million

Aquinox (Vancouver, B.C.) raised US$14.5 million in a series A round led by new investor Ventures West. Johnson & Johnson Development Corp. (JJDC) and Baker Brothers, also new investors, joined existing investor BC Advantage Funds...
00:49 , Aug 17, 2005 |  BC Extra  |  Financial News

OncoGenex raises $12.8 million

OncoGenex (Vancouver, B.C.) raised $12.8 million in a series B2 round. New investors WHI Morula Fund and BC Advantage Funds joined existing investors Ventures West; H.I.G. Ventures; Working Opportunity Fund; and Business Development Bank of...